ING/WellPoint and Aetna may or may not be talking, but several Aetna shareholders definitely want them to. Following Aetna’s rejection of their bid, which analysts valued at close to $70 a share, Aetna announced that it intended to split into two companies. Its shares have since fallen to the low $50s, which is at least better that its eight-year low of $38.50 a share reached in February. The complaining shareholders thought the takeover rejection was an error and have filed suit against Aetna in a Connecticut Superior Court alleging that it refused to adequately consider the ING/WellPoint bid simply to protect current management.
Topics Lawsuits
Was this article valuable?
Here are more articles you may enjoy.
Acrisure to Cut 2,250 Employees, Citing Advances in Technology and AI 
Three New HO Carriers and an Improving Condo Market in Florida, Reports Show 
Safepoint Exec Pay, Slide’s Stock Sell-Offs Getting Attention in Florida 
Texas Chick-fil-A Franchisee Sued for Religious Discrimination From This Issue
